C4 Therapeutics Inc. (CCCC) at a glance

C4 Therapeutics Inc. (CCCC) is a small-cap Healthcare company. It trades at $3.88, with a -297.8% profit margin and revenue decline of 15%. It does not pay a dividend. Vestovix scores it 30/100 overall. Its strongest dimension is Momentum (59/100) and its weakest is Safety (1/100). It carries above-market volatility, so expect larger swings.

Price

$3.89

Market cap

$431.2M

P/E ratio

n/a

Dividend yield

None

Beta

2.93

52-week range

$1.69 to $5.17